You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HiDAC

Showing 1 - 25 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)

Terminated
Has Results
  • Acute Myeloid Leukemia (AML)
  • Allogeneic HCT
  • Consolidation chemotherapy
  • Charlotte, North Carolina
    Levine Cancer Institute
Apr 19, 2022

Mantle Cell Lymphoma, Untreated Trial in United States (Lenalidomide, R-CHOP, high-dose cytarabine (HIDAC))

Active, not recruiting
  • Mantle Cell Lymphoma
  • Untreated
  • Basking Ridge, New Jersey
  • +6 more
Feb 17, 2022

Mantle Cell Lymphoma Trial in United States (R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.)

Active, not recruiting
  • Mantle Cell Lymphoma
  • R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
  • Basking Ridge, New Jersey
  • +4 more
Dec 1, 2022

Acute Myeloid Leukemia Trial (Ficlatuzumab, Cytarabine)

Withdrawn
  • Acute Myeloid Leukemia
  • (no location specified)
Mar 27, 2020

Leukemia, Myeloid, Acute Trial in Germany (Human Stem Cell Transplantation, Consolidation chemo, i.e. High-dose Cytarabine

Terminated
  • Leukemia, Myeloid, Acute
  • Human Stem Cell Transplantation
  • Consolidation chemotherapy, i.e. High-dose Cytarabine (HiDAC)
  • Aachen, Germany
  • +18 more
Oct 28, 2021

Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in San Francisco (Ficlatuzumab,

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Mar 22, 2020

Acute Myeloid Leukemia, in Relapse Trial in Baltimore, Chapel Hill (pembrolizumab,)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia, in Relapse
  • Baltimore, Maryland
  • +1 more
Aug 10, 2022

Acute Myeloid Leukemia Trial in Chicago (Cytarabine, Mitoxantrone Hydrochloride, Selinexor)

Completed
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Apr 6, 2020

Acute Myeloid Leukemia Trial in Gainesville, Saint Louis, Rochester (drug, procedure, device)

Recruiting
  • Acute Myeloid Leukemia
  • Gainesville, Florida
  • +2 more
Aug 30, 2022

Peripheral T-Cell Lymphoma Trial in Saint Louis (Gemcitabine, Navelbine, Doxorubicin Hydrochloride Liposome Injection)

Terminated
Has Results
  • Peripheral T-Cell Lymphoma
  • Saint Louis, Missouri
    Washington University
Apr 14, 2020

Acute Myeloid Leukemia Trial in Poland, United States (A arm (DA-90), B arm (DAC), A arm (CLAG-M))

Recruiting
  • Acute Myeloid Leukemia
  • A arm (DA-90)
  • +3 more
  • New York, New York
  • +9 more
Sep 30, 2021

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Birmingham, Alabama
  • +8 more
Jan 24, 2023

Acute Myeloid Leukemia Trial in Worldwide (guadecitabine, Treatment Choice (TC))

Completed
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +94 more
Sep 5, 2021

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
May 13, 2020

Relapsed/Refractory AML Trial in Tianjin, Hangzhou (Uproleselan, Placebo)

Recruiting
  • Relapsed/Refractory AML
  • Tianjin, Tianjin, China
  • +1 more
Nov 22, 2021

Acute Myeloid Leukemia, Core-Binding Factor Trial in Shanghai (Fludarabine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Core-Binding Factor
  • Shanghai, Shanghai, China
    Xianmin Song
May 5, 2022

Acute Myeloid Leukemia Trial in France (GRASPA)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Nice, Alpes Maritimes, France
  • +20 more
Feb 18, 2022

Acute Myeloid Leukemia Trial in Heidelberg (Bortezomib, Gemtuzumab Ozogamicin)

Recruiting
  • Acute Myeloid Leukemia
  • Heidelberg, Baden-Württemberg, Germany
    University Hospital Heidelberg, Internal Medicine V
May 25, 2020

Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)

Recruiting
  • Newly Diagnosed Acute Myeloid Leukemia (AML)
  • SKLB1028 Dose Escalation
  • Chengdu, China
    West China Hospital of Sichuan University
Jun 30, 2022

Acute Myeloid Leukemia Trial in Spain (Quizartinib, Fludarabine, Cytarabine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Alicante, Spain
  • +19 more
Mar 11, 2022

Acute Myeloid Leukemia Trial in Baltimore (Cytarabine consolidation, Allogeneic transplant)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Cytarabine consolidation
  • Allogeneic transplant
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jul 17, 2018

Acute Myeloid Leukemia Trial in Germany (midostaurin (PKC412))

Completed
  • Acute Myeloid Leukemia
  • midostaurin (PKC412)
  • Chemnitz, Germany
  • +9 more
Aug 5, 2020

AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed

Recruiting
  • AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
  • MRD-triggered arm
  • Prophylactic Arm
  • Heidelberg, BW, Germany
    University Hospital Heidelberg Med5
Jan 4, 2021

Acute Myeloid Leukemia (AML) Trial in Augusta (Remote monitoring of temperature)

Unknown status
  • Acute Myeloid Leukemia (AML)
  • Remote monitoring of temperature
  • Augusta, Georgia
    Augusta University Medical Center
Jan 6, 2020

Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab, Standard of Care Chemotherapy)

Terminated
Has Results
  • Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
  • Duarte, California
  • +116 more
Jan 4, 2022